Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin fMRI in Schizophrenia
NCT04176835Completed
- Sponsor
- National Institute of Mental Health and Neurosciences
- Start
- Apr 2016
- Primary completion
- Sep 2019
01
Overview
Randomised, single-blind trial of oxytocin nasal spray in schizophrenia (2 arms), sponsored by National Institute of Mental Health and Neurosciences. Primary endpoint: fMRI changes with oxytocin while performing ultimatum game and at rest at 90 minutes. Started Apr 2016; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT04176835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04176835.